Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 3
2016 3
2017 4
2018 5
2019 4
2020 5
2021 10
2022 13
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis.
Taliento C, Morciano G, Nero C, Froyman W, Vizzielli G, Pavone M, Salvioli S, Tormen M, Fiorica F, Scutiero G, Scambia G, Giorgi C, Greco P, Pinton P. Taliento C, et al. Among authors: nero c. Int J Gynecol Cancer. 2024 Apr 23:ijgc-2024-005313. doi: 10.1136/ijgc-2024-005313. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38658022
Distribution and prognostic role of BRCA status in elderly ovarian cancer patients.
Tortorella L, Cappuccio S, Giannarelli D, Nero C, Marchetti C, Gallotta V, Costantini B, Pasciuto T, Minucci A, Fagotti A, Scambia G. Tortorella L, et al. Among authors: nero c. Gynecol Oncol. 2024 Mar;182:57-62. doi: 10.1016/j.ygyno.2023.12.022. Epub 2024 Jan 22. Gynecol Oncol. 2024. PMID: 38262239 Free article.
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY).
Nero C, Bizzarri N, Di Berardino S, Sillano F, Vizzielli G, Cosentino F, Vargiu V, De Iaco P, Perrone AM, Vizza E, Chiofalo B, Uccella S, Ghezzi F, Turco LC, Corrado G, Giannarelli D, Pasciuto T, Zannoni GF, Fagotti A, Scambia G. Nero C, et al. Eur J Cancer. 2024 Jan;196:113435. doi: 10.1016/j.ejca.2023.113435. Epub 2023 Nov 14. Eur J Cancer. 2024. PMID: 38006759
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.
Lococo F, Boldrini L, Diepriye CD, Evangelista J, Nero C, Flamini S, Minucci A, De Paolis E, Vita E, Cesario A, Annunziata S, Calcagni ML, Chiappetta M, Cancellieri A, Larici AR, Cicchetti G, Troost EGC, Ádány R, Farré N, Öztürk E, Van Doorne D, Leoncini F, Urbani A, Trisolini R, Bria E, Giordano A, Rindi G, Sala E, Tortora G, Valentini V, Boccia S, Margaritora S, Scambia G. Lococo F, et al. Among authors: nero c. BMC Cancer. 2023 Nov 9;23(1):1082. doi: 10.1186/s12885-023-11606-7. BMC Cancer. 2023. PMID: 37946178 Free PMC article. No abstract available.
Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data.
Agostinelli V, Musacchio L, Camarda F, Salutari V, Carbone MV, Ghizzoni V, Nero C, Ricci C, Perri MT, Giudice E, Lardino S, Berardi R, Scambia G, Lorusso D. Agostinelli V, et al. Among authors: nero c. Cancer Manag Res. 2023 Sep 27;15:1063-1072. doi: 10.2147/CMAR.S294080. eCollection 2023. Cancer Manag Res. 2023. PMID: 37790898 Free PMC article. Review.
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centres.
Schwameis R, Fanfani F, Ebner C, Zimmermann N, Peters I, Nero C, Marth C, Ristl R, Leitner K, Grimm C, Oberndorfer F, Capasso I, Zeimet AG, Polterauer S, Scambia G, Fagotti A, Concin N. Schwameis R, et al. Among authors: nero c. Eur J Cancer. 2023 Nov;193:113317. doi: 10.1016/j.ejca.2023.113317. Epub 2023 Sep 1. Eur J Cancer. 2023. PMID: 37748967 Free article.
58 results